Company intelligence / Profile preview

Tradegate

Ownership: Private
Employees: ~174
Development stage: Other

Overview

Tradegate AG is a leading European financial services provider and the operator of the Tradegate Exchange, a major German stock exchange specializing in retail investors. While not a life science or biotech company itself, it serves as a critical trading platform for numerous global pharmaceutical and biotechnology firms, including BioNTech, AstraZeneca, and Novo Nordisk. The company holds a full banking license and provides a comprehensive range of services across the securities trading value chain. Headquartered in Berlin, Tradegate AG is known for its innovative trading technology and extended trading hours, making it a primary venue for healthcare sector equities in the European market.

Industry: Investors

Partnerships

Deutsche Börse Group

Beyond the preview

Go deeper on Tradegate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tradegate.

Explore the full profile